Zydus Lifesciences Ltd.

Cadila Healthcare has decided to exit from its business in Japan, which is through 100% subsidiary Company after completing portfolio and strategy review of its business.

Cadila Healthcare, the flagship company of Zydus Cadila Group, focuses on various areas, such as formulations (human and veterinary), new drug discovery, novel drug delivery, pharmaceutical ingredients, analytical research, phytochemistry, biotechnology, plant tissue culture, etc.